Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Brain Neoplasms 6Glioma 5Glioblastoma 3Astrocytoma 3Oligodendroglioma 2Keratosis, Actinic 2Skull Base Neoplasms 1Sarcoma 1Precancerous Conditions 1Pituitary Neoplasms 1Oropharyngeal Neoplasms 1Neurofibromatoses 1Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Meningioma 1Leukoplakia, Oral 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Carcinoma, Basal Cell 1

Interventions

Doxorubicin 27Cyclophosphamide 26Radiotherapy 16Gemcitabine 16Filgrastim 11pembrolizumab 10pazopanib 10Radiation 9Docetaxel 9Cisplatin 9fludarabine 7Trabectedin 7Ipilimumab 7Ifosfamide 7Granulocyte Colony-Stimulating Factor 7Etoposide 7Carboplatin 7Busulfan 7Bevacizumab 7olaratumab 6Temozolomide 6Peripheral Blood Stem Cell Transplantation 6Nivolumab 6Mesna 6Melphalan 6selinexor 5Leucovorin 5Irinotecan 5Celecoxib 5Bortezomib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Sarcoma × Aminolevulinic Acid × Clear all
NCT06252727 2024-08-15

Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)

University of California, Davis

Phase 1 Withdrawn
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡